JP2019512006A5 - - Google Patents

Download PDF

Info

Publication number
JP2019512006A5
JP2019512006A5 JP2018541254A JP2018541254A JP2019512006A5 JP 2019512006 A5 JP2019512006 A5 JP 2019512006A5 JP 2018541254 A JP2018541254 A JP 2018541254A JP 2018541254 A JP2018541254 A JP 2018541254A JP 2019512006 A5 JP2019512006 A5 JP 2019512006A5
Authority
JP
Japan
Prior art keywords
peg
pla
poly
dbco
conh2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018541254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019512006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/047807 external-priority patent/WO2017138983A1/en
Publication of JP2019512006A publication Critical patent/JP2019512006A/ja
Publication of JP2019512006A5 publication Critical patent/JP2019512006A5/ja
Pending legal-status Critical Current

Links

JP2018541254A 2016-02-10 2016-08-19 Egfrリガンドを有する治療用ナノ粒子ならびにその作製および使用方法 Pending JP2019512006A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662293609P 2016-02-10 2016-02-10
US62/293,609 2016-02-10
US201662369590P 2016-08-01 2016-08-01
US62/369,590 2016-08-01
PCT/US2016/047807 WO2017138983A1 (en) 2016-02-10 2016-08-19 Therapeutic nanoparticles having egfr ligands and methods of making and using same

Publications (2)

Publication Number Publication Date
JP2019512006A JP2019512006A (ja) 2019-05-09
JP2019512006A5 true JP2019512006A5 (https=) 2019-09-19

Family

ID=59496509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018541254A Pending JP2019512006A (ja) 2016-02-10 2016-08-19 Egfrリガンドを有する治療用ナノ粒子ならびにその作製および使用方法

Country Status (7)

Country Link
US (2) US10137088B2 (https=)
EP (1) EP3413917A4 (https=)
JP (1) JP2019512006A (https=)
CN (1) CN108697815A (https=)
AU (1) AU2016392719A1 (https=)
CA (1) CA3013896A1 (https=)
WO (1) WO2017138983A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX374963B (es) 2011-04-29 2025-03-06 Selecta Biosciences Inc Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
BR122020023215B1 (pt) 2013-05-03 2022-11-22 Selecta Biosciences, Inc Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
JP7242180B2 (ja) 2014-09-07 2023-03-20 セレクタ バイオサイエンシーズ インコーポレーテッド 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
CN110366428B (zh) 2016-12-30 2024-05-17 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
CN109966780B (zh) * 2019-03-21 2021-03-09 浙江工商大学 一种水生贝类蒸煮汤中功能性纳米颗粒的分离方法
AU2020287627A1 (en) 2019-06-04 2021-11-18 Selecta Biosciences, Inc. Formulations and doses of PEGylated uricase
MX2022011248A (es) * 2020-03-11 2022-12-15 Selecta Biosciences Inc Metodos y composiciones relacionados con nanoportadores sinteticos.
WO2022040006A1 (en) * 2020-08-19 2022-02-24 The Trustees Of The University Of Pennsylvania Targeting cartilage egfr pathway for osteoarthritis treatment
CN114133432B (zh) * 2021-11-01 2023-06-16 暨南大学 一种抑制肿瘤细胞生长和转移的靶向肽及其应用
WO2023079677A1 (ja) * 2021-11-05 2023-05-11 日本電信電話株式会社 分子拡散評価方法およびシステム
WO2023079142A2 (en) 2021-11-05 2023-05-11 Targimmune Therapeutics Ag Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
CN114813998B (zh) * 2022-03-24 2023-05-23 天津键凯科技有限公司 一种聚合物的检测方法
CN115006390B (zh) * 2022-06-27 2024-04-19 国药集团动物保健股份有限公司 一种病毒减毒制剂、其制备方法以及应用
CN115317515B (zh) * 2022-07-19 2024-08-20 沈阳药科大学 氯尼达明/牛血清白蛋白/磷酸铁多效协同仿生矿化纳米制剂及制备方法和应用
US20260000700A1 (en) 2022-11-07 2026-01-01 Targimmune Therapeutics Ag Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
IL320618A (en) 2022-11-07 2025-07-01 Targimmune Therapeutics Ag Polyplexes of nucleic acids and targeted pairs containing polyethyleneimine and polyethylene glycol
WO2025238236A1 (en) 2024-05-16 2025-11-20 Targimmune Therapeutics Ag Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol
CN119280422B (zh) * 2024-10-09 2025-09-26 浙江大学 一种生物相容的双靶向药物递送二聚体纳米颗粒的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834920B2 (en) * 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
US8278415B2 (en) * 2006-12-21 2012-10-02 Centocor, Inc. Dimeric high affinity EGFR constructs and uses thereof
AU2009213141A1 (en) 2008-02-14 2009-08-20 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind EGFR
CN102099016A (zh) * 2008-06-16 2011-06-15 佰恩德生物科学股份有限公司 载药的聚合物纳米微粒及其制备和使用方法
US8318211B2 (en) * 2008-06-16 2012-11-27 Bind Biosciences, Inc. Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
EA020954B1 (ru) * 2008-06-16 2015-03-31 Бинд Терапьютикс, Инк. Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
WO2010091187A2 (en) * 2009-02-04 2010-08-12 The Brigham And Women's Hospital, Inc. Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
EP2618846A1 (en) * 2010-09-24 2013-07-31 Mallinckrodt LLC Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers
US20140308363A1 (en) * 2011-05-31 2014-10-16 Bind Therapeutics, Inc. Drug loaded polymeric nanoparticles and methods of making and using same
CA2878059A1 (en) * 2012-07-31 2014-02-06 The University Of Akron Polymeric structures containing strained cycloalkyne functionality for post-fabrication azidealkyne cycloaddition functionalization
US20160039877A1 (en) * 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
CN104045699A (zh) * 2013-03-15 2014-09-17 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
WO2015157213A1 (en) * 2014-04-08 2015-10-15 California Institute Of Technology Egfr-targeted nanoparticles
CN103893124B (zh) * 2014-04-24 2016-08-24 中国药科大学 基于协同组装的基因治疗药物递送系统

Similar Documents

Publication Publication Date Title
JP2019512006A5 (https=)
Afsharzadeh et al. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
JP2014531456A5 (https=)
Cheng et al. Tandem synthesis of core− shell brush copolymers and their transformation to peripherally cross-linked and hollowed nanostructures
Baranello et al. Poly (styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells
Yang et al. Synthesis and physicochemical characterization of amphiphilic triblock copolymer brush containing pH-sensitive linkage for oral drug delivery
Callari et al. Polymers with platinum drugs and other macromolecular metal complexes for cancer treatment
Kumar et al. N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells
Dhanikula et al. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery
Zhang et al. Poly (l-histidine) based triblock copolymers: pH induced reassembly of copolymer micelles and mechanism underlying endolysosomal escape for intracellular delivery
Yu et al. Functional polylactide-g-paclitaxel–poly (ethylene glycol) by azide–alkyne click chemistry
Duong et al. Acid degradable and biocompatible polymeric nanoparticles for the potential codelivery of therapeutic agents
Hoang et al. Triblock copolymers for nano-sized drug delivery systems
Seidi et al. Functional materials generated by allying cyclodextrin-based supramolecular chemistry with living polymerization
JP2011507946A5 (https=)
JP2015528510A5 (https=)
Aghajanzadeh et al. The role of miktoarm star copolymers in drug delivery systems
Jiang et al. A pH-sensitive nano drug delivery system of doxorubicin-conjugated amphiphilic polyrotaxane-based block copolymers
Li et al. Series of new β-cyclodextrin-cored starlike carriers for gene delivery
Qiu et al. Use of pH-active catechol-bearing polymeric nanogels with glutathione-responsive dissociation to codeliver bortezomib and doxorubicin for the synergistic therapy of cancer
Nguyen et al. Folate‐conjugated chitosan‐pluronic P123 nanogels: synthesis and characterizations towards dual drug delivery
Chen et al. Poly (2-(diethylamino) ethyl methacrylate)-based, pH-responsive, copolymeric mixed micelles for targeting anticancer drug control release
Burts et al. Brush‐first and Click: Efficient Synthesis of Nanoparticles that Degrade and Release Doxorubicin in Response to Light
Chen et al. Amphiphilic poly (ethylene glycol)-b-poly (ethylene brassylate) copolymers: One-pot synthesis, self-assembly, and controlled drug release
Li et al. Synthesis and characterization of dendritic star-shaped zwitterionic polymers as novel anticancer drug delivery carriers